Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/7/25 16:05 | 3/5/25 | TEVA | Health | Drug | Pharmaceutical Preparations | Daniell Richard | L3 | O | EVP,Euro | 3 | S.dm | -4,345 | 15.88 | 0 | -274 | 97 | D | |||||||||||||||
3/6/25 16:19 | 3/4/25 | TEVA | Health | Drug | Pharmaceutical Preparations | Fox Christine | L3 | O | EVP,Head | 1 | S.dm | -98 | 15.80 | 0 | -6 | 58 | D | |||||||||||||||
3/6/25 16:16 | 3/4/25 | TEVA | Health | Drug | Pharmaceutical Preparations | McAvoy David R. | L3 | O | EVP,GC | 1 | S.dm | -76 | 15.80 | 0 | -5 | 12 | D | |||||||||||||||
3/6/25 16:11 | 3/4/25 | TEVA | Health | Drug | Pharmaceutical Preparations | Hughes Eric A | L3 | O | See "Rem | 2 | S.dm | -767 | 15.93 | 0 | -48 | -100 | 0 | D | ||||||||||||||
3/6/25 16:03 | 3/4/25 | TEVA | Health | Drug | Pharmaceutical Preparations | Francis Richard D | L3 | O | P,CEO | 3 | S.dm | -2,158 | 16.52 | 0 | -131 | 272 | D | |||||||||||||||
3/4/25 16:02 | 2/28/25 | TEVA | Health | Drug | Pharmaceutical Preparations | Kalif Eliyahu Sharon | L3 | O | EVP,CFO | 1 | S.d | -903 | 16.21 | 0 | -56 | 198 | D | |||||||||||||||
2/14/25 16:03 | 2/12/25 | TEVA | Health | Drug | Pharmaceutical Preparations | Sabag Mark | L3 | O | See "Rem | 1 | S | -2,887 | 16.25 | 0 | -178 | 205 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |